09.03.2018
- Martin Shkreli, who gained notoriety in 2015 for jacking up the price of Daraprim (pyrimethamine), a 62-year-old drug used to treat toxoplasmosis, has been ordered by a US federal...
27.09.2017
- Investigation into future trends in the medical and pharmaceutical sector shows that digitalization is changing supply chains in the healthcare industry. Such diverse issues like...
09.08.2017
- Martin Shkreli, the eccentric former CEO of Turing Pharmaceuticals, who made headlines in 2015 by jacking up the price of Daraprim (pyrimethamine), a 62-year-old drug used to treat...
27.04.2017
- The US Food and Drug Administration (FDA) has sent warning letters to 14 US-based companies it accuses of illegally selling more than 65 products fraudulently claiming to prevent...
15.07.2016
- A US federal judge has set Jun. 26, 2017 as the trial date for Martin Shkreli, the 33-year-old founder of Retrophin and Turing Pharmaceuticals and former CEO of KalaBios as well as...
18.06.2015
- Sandoz, Inc., the US arm of Novartis’ generic drugs division, is asking the Supreme Court of the US state of Mississippi to reverse a county court’s $38.2 million judgment against...
19.11.2014
- A US subsidiary of AkzoNobel based in Chicago has been been defrauded of up to €53 million, the Dutch chemical producer said, without providing details. The company said it had...
11.06.2013
- A former Bristol-Myers Squibb finance executive on Monday pleaded guilty to an insider trading charge, admitting to buying stock options in a biotechnology company that the...
